Determination of Lentiviral Infectious Titer by a Novel Droplet Digital PCR Method.

Q1 Immunology and Microbiology Human Gene Therapy Methods Pub Date : 2018-04-01 Epub Date: 2018-03-02 DOI:10.1089/hgtb.2017.198
Yu Wang, Svetlana Bergelson, Marina Feschenko
{"title":"Determination of Lentiviral Infectious Titer by a Novel Droplet Digital PCR Method.","authors":"Yu Wang,&nbsp;Svetlana Bergelson,&nbsp;Marina Feschenko","doi":"10.1089/hgtb.2017.198","DOIUrl":null,"url":null,"abstract":"<p><p>Lentivirus is one of the best vehicles in delivering exogenous genes for therapeutics. Prior to application, it is very important to determine the infectious titer, which measures only mature virus capable of infecting target cells. Quantitative polymerase chain reaction (PCR) and fluorescence-activated cell sorting are commonly used for determination of infectious titer. This study introduces a new method based on Droplet Digital PCR (ddPCR), a recently developed PCR technology that quantifies the absolute amount of target DNA in the reaction. In this study, the dynamic range, Limit of Quantification (LOQ), and data acceptance criteria for ddPCR are defined against lentiviral sequence. ddPCR performance is also compared to established FACS and qPCR methods. This work not only demonstrates the feasibility of ddPCR in determining lentiviral infectious titer, but provides a detailed method that can be easily adapted by the scientific community.</p>","PeriodicalId":13126,"journal":{"name":"Human Gene Therapy Methods","volume":"29 2","pages":"96-103"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/hgtb.2017.198","citationCount":"23","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Gene Therapy Methods","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/hgtb.2017.198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/3/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 23

Abstract

Lentivirus is one of the best vehicles in delivering exogenous genes for therapeutics. Prior to application, it is very important to determine the infectious titer, which measures only mature virus capable of infecting target cells. Quantitative polymerase chain reaction (PCR) and fluorescence-activated cell sorting are commonly used for determination of infectious titer. This study introduces a new method based on Droplet Digital PCR (ddPCR), a recently developed PCR technology that quantifies the absolute amount of target DNA in the reaction. In this study, the dynamic range, Limit of Quantification (LOQ), and data acceptance criteria for ddPCR are defined against lentiviral sequence. ddPCR performance is also compared to established FACS and qPCR methods. This work not only demonstrates the feasibility of ddPCR in determining lentiviral infectious titer, but provides a detailed method that can be easily adapted by the scientific community.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新型液滴数字PCR法测定慢病毒感染滴度。
慢病毒是传递外源基因用于治疗的最佳载体之一。在应用之前,确定感染滴度是非常重要的,它只测量能够感染靶细胞的成熟病毒。定量聚合酶链反应(PCR)和荧光活化细胞分选是常用的测定感染滴度。本研究介绍了一种基于液滴数字PCR (ddPCR)的新方法,这是一种最新发展的PCR技术,可以定量反应中目标DNA的绝对数量。在本研究中,针对慢病毒序列定义了ddPCR的动态范围、定量限(LOQ)和数据接受标准。ddPCR的性能也与已建立的FACS和qPCR方法进行了比较。这项工作不仅证明了ddPCR测定慢病毒感染滴度的可行性,而且提供了一种详细的方法,可以很容易地被科学界采用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Human Gene Therapy Methods
Human Gene Therapy Methods BIOTECHNOLOGY & APPLIED MICROBIOLOGY-GENETICS & HEREDITY
CiteScore
5.80
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases. The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.
期刊最新文献
Lot-to-Lot Variation in Adeno-Associated Virus Serotype 9 (AAV9) Preparations. Fast-Seq: A Simple Method for Rapid and Inexpensive Validation of Packaged Single-Stranded Adeno-Associated Viral Genomes in Academic Settings. LINC00958 Accelerates Cell Proliferation and Migration in Non-Small Cell Lung Cancer Through JNK/c-JUN Signaling. Nanoparticle Tracking of Adenovirus by Light Scattering and Fluorescence Detection. LINC00958 accelerates cell proliferation and migration in non-small cell lung cancer through JNK/c-JUN signaling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1